--- schema_type: "SoftwareApplication" entity_type: "Mobile Application" app_name: "Pill Identifier by Drugs.com" developer_entity: "Drugs.com" bundle_id: "com.drugs.pillidlite" app_store_id: "398305495" google_play_id: "com.openvideo.ai.pill.identifier" category: "Medical" primary_platform: "ios" primary_monetization: "Freemium" offline_capable: false market_region: "US" platforms: "iOS & Android" app_last_updated: "2026-04-09" report_date: "2026-04-12" report_version: "2.158" total_reviews: 153 overall_rating: 3.42 sentiment: "Frustrated" sentiment_score: 25 confidence: "high" confidence_score: 0.9 data_age_days: 58 intelligence_version: 4 nemesis: "Pill Identifier Search" competitor_count: 7 tags: ["medical", "freemium", "frustrated sentiment", "mobile app", "app review", "app analysis", "patients,", "caregivers,", "healthcare"] canonical_url: "https://marlvel.ai/intel-report/medical/com-drugs-pillidlite" license: "CC-BY-NC 4.0" last_verified: "2026-04-17T19:51:18.413Z" --- # Pill Identifier by Drugs.com App Audit > **TL;DR:** Pill Identifier by Drugs.com is a medical app by Drugs.com, rated 3.42/5 by 153 users, with Frustrated user sentiment (25/100), available on iOS & Android. > > **Marlvel.ai App Intelligence** β€” Independent analysis. US Market. No publisher influence. > **Key Insight:** Pill Identifier by Drugs.com faces Frustrated user sentiment (3.42/5 from 153 reviews), with inaccurate/incomplete database as the primary user concern. ## Quick Facts | Fact | Value | | :--- | :--- | | **Rating** | 3.42/5 (153 reviews) | | **User Mood** | Frustrated | | **Category** | Medical | | **Developer** | Drugs.com | | **Pricing** | Freemium | | **Platforms** | iOS & Android | | **Confidence** | High (0.9/1.0) | | **Data Age** | 0d | ## Metadata & Market Performance - **Publisher:** Drugs.com - **Category:** Medical - **Target Audience:** Patients, caregivers, and healthcare professionals seeking quick medication identification and safety information. - **Platforms:** iOS & Android - **Version Audited:** 2.158 - **Audit Date:** 2026-04-12 - **Signal Count:** 153 reviews analyzed - **Confidence:** High (0.9/1.0) - **App Store ID (iOS):** 398305495 - **Bundle ID:** com.drugs.pillidlite - **Google Play ID:** com.openvideo.ai.pill.identifier - **Performance Trend:** Declining - **Data Window:** Analysis based on signals collected up to 2026-04-12 - **Short Description:** AI Pill finder, Drug guide, Drug Search ## Executive Snapshot Pill Identifier by Drugs.com is a medical utility leveraging AI image recognition to identify medications. While it holds a strong brand position and recently climbed to #25 in Paid Medical apps (US), it suffers from an 'Upset' user base. The primary value proposition of instant identification is currently undermined by database gaps and a high-friction $9.99/week subscription model that users feel does not match the app's reliability. ## App DNA (Features & Intent) - **[Differentiator] AI Image Recognition:** Snap a photo or upload an image to identify pills instantly using advanced recognition technology * *User Intent:* Users expect intelligent, adaptive experiences that learn from their behavior. - **[Standard] Comprehensive Drug Database:** Access detailed information on over 24,000 prescription and OTC medications * *User Intent:* Users expect intelligent, adaptive experiences that learn from their behavior. - **[Standard] Search by Physical Attributes:** Search for medications based on imprint, drug name, color, and shape * *User Intent:* Users want to quickly find relevant content or features. ## Monetization Strategy - **Model:** Freemium - **Tiers:** Free version with basic search, Pill Identifier Pro: $9.99/week, Pill Identifier Pro: $29.99/year - **Price:** iOS: $0.99 - **Analysis:** The $9.99/week price point is extremely aggressive for a utility app, creating a 'value gap' when the database fails to identify a pill. This model contrasts sharply with WebMD's free, ad-supported approach. ## πŸ”΄ User Sentiment (High Confidence: 153 reviews) {#user-sentiment} - **Overall Rating:** 3.42/5 - **Platform Split:** iOS 3.4/5 (142 ratings) | Android 3.2/5 (11 ratings) - **Overall Sentiment:** Frustrated ### Top Praises - **Utility for Identification** | *Evidence:* "Helps me identify medications FAST AND QUICK!" ### Top Complaints (Impact Areas) - **Inaccurate/Incomplete Database** | *Evidence:* "This medium pink pill is not in your database" - **Poor Search Functionality** | *Evidence:* "The filters for shape and color disappear when you type in an imprint" ## SWOT Analysis **Core Strengths:** - Drugs.com brand authority - AI-driven photo recognition - Integration with broader drug info ecosystem **Critical Frictions:** - High $9.99/week subscription cost - Database gaps for common/generic drugs - Search UI bugs (disappearing filters) **Growth Levers:** - Expansion of AI for multi-colored pills - Professional-tier clinical features - Offline database access **Market Threats:** - Free tools from WebMD - AI-first startups like Pill Eye - High churn due to 'no match' results ## What's Changed (v3 β†’ v4) {#recent-changes} The app shifted to a freemium model and is experiencing a decline in sentiment due to technical UI bugs and database coverage gaps that undermine its high-priced subscription. - **[HIGH]** **[Shifted] Freemium Model Adoption:** The pricing model transitioned from a strict subscription-only structure to a freemium model, though the $9.99/week Pro tier remains. - **[HIGH]** **[Declined] Sentiment Score Drop:** Sentiment score decreased from 32 to 25, driven by increased complaints regarding database accuracy and new UI bugs. - [MED] **[Declined] Search UI Regression:** Users report that search filters for shape and color disappear when entering an imprint, breaking the core identification workflow. - [MED] **[Added] New Weaknesses and Threats:** Added 'Search UI bugs' as a weakness and 'High churn due to no match results' as a specific threat. ## Rivals Landscape {#rivals} > Competitive positioning identified by AI analysis of app features, category, and market signals. ### Pill Identifier by Drugs.com vs Pill Identifier Search β€” Head to Head - **Pill Identifier Search** by Silver Star Apps: This is the most direct utility competitor, focusing exclusively on the same core 'identify by imprint' and 'identify by photo' use cases with a similar subscription-based monetization model. - **Key differences:** - Stronger user sentiment regarding database accuracy - More streamlined, utility-first user interface - Higher frequency of technical bug fixes and performance updates - **Publisher (Silver Star Apps) strengths:** Specializes in high-utility medical and productivity tools; Strong track record of maintaining high App Store ratings across niche utilities - **Where Pill Identifier by Drugs.com wins:** - βœ… Direct integration with the broader Drugs.com information ecosystem - βœ… AI-driven photo recognition is marketed as a core feature rather than a secondary tool - **Where Pill Identifier Search wins:** - ❌ Significantly higher user satisfaction and rating stability - ❌ More reliable search functionality for obscure generic imprints - **Verdict:** Pill Identifier Search currently holds the edge due to stronger sentiment and a more reliable search engine. While the Drugs.com app leverages a powerful brand name, its technical instability and mixed reviews on database accuracy make it a secondary choice for power users. ### Contenders (Strong Challengers) - **WebMD** by WebMD: The dominant consumer health platform that includes a highly popular, free Pill Identification tool used by millions. - Massive, authoritative content library beyond just pill identification - Completely free access to identification tools supported by an ad-model - **Epocrates** by Epocrates: The gold standard for medical professionals, offering high-precision pill identification and clinical drug references. - Professional-grade clinical data trusted by healthcare providers - Superior drug interaction checker with multi-drug analysis - **Medscape** by WebMD: A high-authority clinical reference tool that competes directly for the professional user base needing reliable drug identification. - Extensive database of over 8,500 prescription and OTC drugs - Visual pill identification tool optimized for clinical environments ### Peers (What They Do Better) - **[Medisafe Medication Management](https://marlvel.ai/intel-report/medical/com-medisafe-medisafe)** by Medisafe: The leading medication reminder app that shares the same target audience of patients managing multiple prescriptions. - Focuses on adherence and tracking rather than just identification - Includes family sync features and caregiver notifications - **Pillboxie** by Pillboxie: A visual medication manager that allows users to 'drop' pills into a virtual pillbox, appealing to the same visual-oriented users. - Highly visual, skeuomorphic interface for pill management - Works without an internet connection for core features ### New Kids on the Block (What's Innovative) - **Pill Eye** by Pill Eye: A newer, AI-first competitor that focuses almost exclusively on the 'snap a photo' identification method to disrupt traditional search. - Specialized computer vision model specifically for pill geometry - Minimalist interface designed for speed and instant results ## The "So What?" (Strategic Takeaway) {#so-what} Pill Identifier by Drugs.com is a challenged medical app that is free with in-app purchases. With a 3.42/5 rating from 153 reviews, it faces significant user friction. > **Bottom Line:** The app is currently coasting on the Drugs.com brand name but is at high risk of churn due to a 'value gap'β€”the $9.99/week price is too high for a database that frequently returns 'no match.' To defend its #25 ranking, the PM must prioritize fixing the search UI and expanding the imprint library to match the reliability of the Nemesis, Pill Identifier Search. **Best for:** Patients, caregivers, and healthcare professionals seeking quick medication identification and safety information. ### PM Action Plan (Next Best Moves) - [ ] [HIGH] Fix Search UI Filter Persistence β€” *Users report filters for shape and color disappear when typing imprints, breaking the core search workflow (Sentiment Analysis).* - [ ] [HIGH] Audit Database for Generic Imprints β€” *High-frequency complaints regarding 'no match' for common drugs like Kenzoflex indicate a database coverage gap that invalidates the Pro subscription value (Sentiment Analysis).* - [ ] [MEDIUM] Re-evaluate Weekly Subscription Pricing β€” *The $9.99/week price point is cited as a friction point when technical bugs occur, whereas competitors like Pill Identifier Search offer more stability (Competitor Analysis).* ### Feature Gaps vs Competitors - Reliable search for obscure generic imprints (available in Pill Identifier Search) - Multi-drug interaction analysis (available in Epocrates) - Offline mode (available in Pillboxie) ### Outlook: Declining - πŸ”΄ Upset user sentiment driven by database gaps and UI bugs. - 🟒 v2.158 (April 2026) update shows active maintenance of the imprint library. - πŸ”΄ High-friction $9.99/week pricing model creates immediate churn when AI recognition fails. ## Key Metrics Summary | Metric | Value | | :--- | :--- | | Overall Rating | 3.42/5 | | Total Reviews | 153 | | Sentiment | Frustrated (25/100) | | Confidence | High | | Pricing Model | Freemium | | Platforms | iOS & Android | | Key Features | 3 analyzed | | Trend | Declining | | Outlook | Declining | ## Competitor Comparison | App | Rating | Sentiment | Developer | | :--- | :--- | :--- | :--- | | **Pill Identifier by Drugs.com** (this app) | 3.42/5 | Frustrated | Drugs.com | | [Medisafe Medication Management](https://marlvel.ai/intel-report/medical/com-medisafe-medisafe) | 4.7/5 | N/A | MediSafe Inc. | | [FHO+ Calc](https://marlvel.ai/intel-report/medical/ca-fhocalc-app) | N/A/5 | N/A | Manu Kaushik | | [MyBaby Milestones Baby Tracker](https://marlvel.ai/intel-report/medical/mybaby-milestones-baby-tracker) | 4.6/5 | N/A | Sebastien Menozzi | | [ASE TTE](https://marlvel.ai/intel-report/medical/com-redpixelstudios-medmovie-ase-tte) | N/A/5 | N/A | Medmovie, Inc. | | [Total Reflexology-3D](https://marlvel.ai/intel-report/medical/com-acupuncturelearning-totalreflexology) | 4.0/5 | N/A | GraphicVizion | ## Company Profile - **Developer:** Drugs.com - **Website:** [https://www.drugs.com/apps/](https://www.drugs.com/apps/) - **Social:** [Instagram](https://www.instagram.com/drugs.com_official) Β· [Facebook](https://www.facebook.com/Drugscom) Β· [X/Twitter](https://twitter.com/drugscom) Β· [YouTube](https://www.youtube.com/user/drugscom) ## Data Sources & Links - **App Store:** [View on Apple Store](https://apps.apple.com/us/app/pill-identifier-by-drugs-com/id398305495?uo=2) - **Google Play:** [View on Google Play](https://play.google.com/store/apps/details?id=com.openvideo.ai.pill.identifier&hl=en&gl=us) - **Dev Site:** [Official Website](https://www.drugs.com/apps/) - **Sources:** Developer website content, About us / company information, App store metadata, User reviews. ## Related Intel Reports - [*Medisafe Medication Management*](https://marlvel.ai/intel-report/medical/com-medisafe-medisafe) (MediSafe Inc.) β€” 4.7/5 Rating | N/A Sentiment - [*FHO+ Calc*](https://marlvel.ai/intel-report/medical/ca-fhocalc-app) (Manu Kaushik) β€” N/A Rating | N/A Sentiment - [*MyBaby Milestones Baby Tracker*](https://marlvel.ai/intel-report/medical/mybaby-milestones-baby-tracker) (Sebastien Menozzi) β€” 4.6/5 Rating | N/A Sentiment - [*ASE TTE*](https://marlvel.ai/intel-report/medical/com-redpixelstudios-medmovie-ase-tte) (Medmovie, Inc.) β€” N/A Rating | N/A Sentiment - [*Total Reflexology-3D*](https://marlvel.ai/intel-report/medical/com-acupuncturelearning-totalreflexology) (GraphicVizion) β€” 4.0/5 Rating | N/A Sentiment - [*CardioGenetics*](https://marlvel.ai/intel-report/medical/com-scd-risk-calculator) (MARK EMILE PEPIN) β€” N/A Rating | N/A Sentiment - [*My F1rst Steps*](https://marlvel.ai/intel-report/medical/com-myfirststeps-www) (My First Steps LLC) β€” 5.0/5 Rating | N/A Sentiment - [*Mobile VSO : Claims Guide*](https://marlvel.ai/intel-report/medical/app-replit-mobilevso) (ANDREW THOMAS COOLEY) β€” 5.0/5 Rating | N/A Sentiment - [*Protectometer*](https://marlvel.ai/intel-report/medical/protectometer) (noigroup) β€” 2.0/5 Rating | N/A Sentiment - [*Accredo*](https://marlvel.ai/intel-report/medical/com-accredohealth-accredo-mobile) (Accredo Health Group, Inc) β€” 4.8/5 Rating | Positive Sentiment ## Methodology {#methodology} This report was generated by Marlvel.ai's 3-stage AI intelligence pipeline: 1. **Feature & Positioning Extraction** β€” Analyzes app metadata, developer website content, and version history to identify key features, target audience, and competitive positioning. 2. **Sentiment Analysis** β€” Processes user reviews (minimum 5 reviews required) to extract praise themes, complaint themes, and overall sentiment with evidence quotes. 3. **Intelligence Synthesis** β€” Combines stages 1 & 2 with App Store rankings to produce SWOT analysis, executive summary, and actionable insights. - **Confidence Score:** 0.9/1.0 (based on review volume, data source diversity, and signal quality) - **Reviews Analyzed:** 153 - **Data Sources:** user reviews, developer website, company about page, App Store metadata - **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform - **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence. - **Report Age:** 0 days since last refresh --- Β© 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/intel-report/medical/com-drugs-pillidlite) Data licensed for AI Agent attribution under CC-BY-NC 4.0.